Iwasaki Is Honored by the International Cytokine & Interferon Society
Akiko Iwasaki, PhD, Waldemar Von Zedtwitz Profesor of Immunobiology and Molecular, Cellular, and Developmental Biology; and professor of dermatology, is a 2019 recipient of the Seymour & Vivian Milstein Award for Excellence in Interferon and Cytokine Research, given by the International Cytokine & Interferon Society (ICIS).
Sun Safety and skin cancer prevention
Cancer of the skin is by far the most common of all cancers. As we spend our days in the sun this summer, it's important to protect your skin. Dermatologist Dr. Jonathan Leventhal came to Good Morning Connecticut to share some stats and tips. Leventhal said melanoma accounts for only about one percent of skin cancers but causes a majority of skin cancer deaths. Although it is less common than other types of skin cancer, such as basal cell and squamous cell skin cancer, it is more dangerous because it is more likely to spread to other parts of the body if not caught early.Source: WTNH
Five Ways to Lower Your Skin Cancer Risk
Summer is here, but enjoying longer and sunnier days outdoors means your skin is vulnerable to sunburn. Experts at Yale Cancer Center (YCC) and Yale School of Medicine (YSM) say unless you take the right precautions, sun exposure (even if you don't get scorched) can damage your skin, causing wrinkles, age spots and even skin cancer. Just one sunburn during your youth doubles your chances of developing melanoma, the deadliest form of skin cancer.
How Cell Biologists Work: Valentina Greco on cultivating a passionate research team
Valentina Greco is an Associate Professor in the Departments of Genetics, Cell Biology and Dermatology at Yale University, and is a member of the Yale School of Medicine Stem Cell Center and Cancer Center. The Greco lab is shedding new light on the mysterious lives of stem cells. Using stunning in vivo imaging of intact tissues, they reveal how stem cells are regulated and deployed during normal tissue maintenance and in tissue repair.Source: ASCB
See an 'onco-dermatologist' for cancer-related skin, hair and nail problems
Onco-dermatologists care for skin, hair and nail reactions from cancer therapy. Not only do these pose additional physical and emotional stress at an already-difficult time in cancer patients’ lives, they also can compromise the therapy.Source: YaleMedicine.org
Tanning Dependence Linked to Other Addictive Behaviors, New Study Finds
Despite the known dangers of exposure to ultraviolet light, many people continue to sunbathe and use indoor tanning beds with some users exhibiting a dependence to tanning. A new study from the Yale School of Public Health finds that such dependence is also associated with other addictive behaviors.
Treatment for late stage skin cancer works with body’s immune system
Working with the body’s immune system in the battle against Melanoma. Cancer research is moving more into what’s called Immuno-oncology. Patients like Mary Mannion are benefiting. Mary’s skin cancer was first detected on her leg. “I think it’s right here,” as she points to a faint scar, “I had a mole that changed shape, size, color.” Stage-four Melanoma.Surgeons removed it and Mary underwent targeted therapy. Eleven years later, the cancer came back. She says, “The Melanoma had metastasized here,” pointing to her chest area. Most Melanomas start on the skin says Mary’s doctor. “The problem is those cells can travel through the blood stream to other parts of the body,” says Dr. Mario Sznol at Smilow Cancer Hospital at Yale-New Haven.Source: WTNH News Channel 8
Scientists rehash evidence on sunscreen and skin cancer
There isn't much evidence to conclusively prove that daily sunscreen use can prevent most skin cancers, a research review concludes. But that doesn't mean we shouldn't use sunscreen, doctors say. It just means it's unethical to do experiments testing the effectiveness of sunscreen by randomly assigning some people to use it and others to skip it.Source: Fox News
Yale Cancer Center researchers win Sokoloff Family-Melanoma Research Alliance team science award
A new approach to understanding why T-cells are often too weak to fight and destroy tumor cells has earned Yale Cancer Center researchers team science award from the Sokoloff Family-Melanoma Research Alliance (MRA).
Central Nervous System Inflammation: A Pathway and Possible Drug Target
Scientists have long known that the central nervous system (CNS) has a remarkable ability to limit excessive inflammation in the presence of antigens or injury, but how it works has been unclear. Now, Yale researchers have identified a mechanism that offers this new insight into this protective effect. The findings were described in the April 8 journal of Science Advances.
Yale study identifies ‘major player’ in skin cancer genes
A multidisciplinary team at Yale, led by Yale Cancer Center members, has defined a subgroup of genetic mutations that are present in a significant number of melanoma skin cancer cases. Their findings shed light on an important mutation in this deadly disease, and may lead to more targeted anti-cancer therapies.
Mutation Mystery: A Clinician Seeks Answers to Improve Skin Cancer Treatment for Women
Dr. Christine Ko has launched a study to see if a mutated gene can serve as a biological marker to predict the growth rate and recurrence of squamous cell carcinoma, a type of tumor of the thin outer layer of skin that affects about 700,000 Americans each year.